Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients.
Datta NR, Heuser M, Samiei M, Shah R, Lutters G, Bodis S.
Telemed J E Health. 2015 Jul;21(7):523-32. doi: 10.1089/tmj.2014.0154. Epub 2015 Mar 12.
[The role of teleradiotherapy in treatment of thyroid cancer].
Reinfuss M, Kowalska T, Skotnicki P.
Wiad Lek. 2001;54 Suppl 1:326-30.
The future of image-guided radiotherapy will be MR guided.
Pollard JM, Wen Z, Sadagopan R, Wang J, Ibbott GS.
Br J Radiol. 2017 May;90(1073):20160667. doi: 10.1259/bjr.20160667. Epub 2017 Mar 29.
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P.
Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2.
Therapy of uveal melanoma A Review.
Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer L.
Cesk Slov Oftalmol. 2020 Fall;77(1):1-13. doi: 10.31348/2020/10.
[Teleradiotherapy and ai'-gammatherapy].
SLUYS F.
J Belge Radiol. 1956;39(4):572-82.
Teleradiotherapy of joints in rheumatoid arthritis: lack of efficacy.
Graninger M, Handl-Zeller L, Hohenberg G, Staudenherz A, Kainberger F, Graninger W.
Ann Rheum Dis. 2005 Jan;64(1):138-40. doi: 10.1136/ard.2004.021766.
Improvement of radiotherapy facilities in developing countries: a three-tier system with a teleradiotherapy network.
Datta NR, Rajasekar D.
Lancet Oncol. 2004 Nov;5(11):695-8. doi: 10.1016/S1470-2045(04)01613-4.
Circulating CXCL9 and CXCL10 as markers of activity of Graves' orbitopathy during treatment with corticosteroids and teleradiotherapy.
Mysliwiec J, Palyga I, Kosciuszko M, Kowalska A, Gorska M.
Horm Metab Res. 2012 Dec;44(13):957-61. doi: 10.1055/s-0032-1316352. Epub 2012 Jun 29.
[Neoadiuvant teleradiotherapy decreases cancer tissue and serum concentration of prostaglandin E2 and cyclooxygenase-2 expression in patients with rectal cancer].
Mularczyk A, Gonciarz M.
Pol Merkur Lekarski. 2016 Aug;41(242):70-3.
